Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Role, Controversy, and Future Directions.

about

Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Role, Controversy, and Future Directions.

Item

http://www.wikidata.org/entity/Q52596125

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Induction Chemotherapy in Loca ...... oversy, and Future Directions.

@en

Induction Chemotherapy in Loca ...... oversy, and Future Directions.

@nl

type

Item

label

Induction Chemotherapy in Loca ...... oversy, and Future Directions.

@en

Induction Chemotherapy in Loca ...... oversy, and Future Directions.

@nl

prefLabel

Induction Chemotherapy in Loca ...... oversy, and Future Directions.

@en

Induction Chemotherapy in Loca ...... oversy, and Future Directions.

@nl

P1476

Induction Chemotherapy in Loca ...... oversy, and Future Directions.

@en

P2093

E E W Cohen

http://www.w3.org/2001/XMLSchema#string

J B Vermorken

http://www.w3.org/2001/XMLSchema#string

J Schulten

http://www.w3.org/2001/XMLSchema#string

J-L Lefebvre

http://www.w3.org/2001/XMLSchema#string

M Posner

http://www.w3.org/2001/XMLSchema#string

R Hitt

http://www.w3.org/2001/XMLSchema#string

R I Haddad

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus and survival of patients with oropharyngeal cancer.

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN).

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323

P304

1130-1140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDY102

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29635316

http://www.w3.org/2001/XMLSchema#string

P932

5961254

http://www.w3.org/2001/XMLSchema#string